Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function

BACKGROUND: Direct-acing antiviral agents are highly efficient treatment options for chronic hepatitis C virus (HCV) infection after renal allograft transplantation. Treatment options for patients with impaired graft function remain limited. Therefore, we assessed the effectiveness and safety of gra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transplant Direct
Autors principals: Eisenberger, Ute, Friebus-Kardash, Justa, Guberina, Hana, Kribben, Andreas, Witzke, Oliver, Willuweit, Katharina, Gerken, Guido, Herzer, Kerstin
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2018
Matèries:
Kidney Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324915/
https://ncbi.nlm.nih.gov/pubmed/30656217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000860
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars